Entity
  • Oroxcell

    Created in 2004
  • Social networks

    1,000
  • Activities

  • Technologies

  • Entity types

  • Location

    102 Av. Gaston Roussel, 93230 Romainville, France

    Romainville

    France

  • Employees

    Scale: 11-50

    Estimated: 16

  • SIREN

    478007503
  • Engaged corporates

    0
    0 0
  • Added in Motherbase

    3 years, 2 months ago
Description
  • Value proposition

    Highlight Innovation

    Oroxcell is an independent research organization (CRO) offering research services assessing the safety, toxicity and efficacy of active ingredients and finished formulations.

    Specialized in in-vitro testing, particularly in 3D Human Models, Oroxcell is developing its business on two fronts:

    • Safety & efficacy testing: From screening to GLP Compliant studies, we provide well established In-vitro platform, 2D and 3D models, for performing routine and regulatory safety testing, ADME (Absorption, Distribution, Metabolism, and Elimination) and Toxicity (sensitization, phototoxicity and genotoxicity) tests, bioanalytical studies, for evaluating pharmaceuticals, medical devices, cosmetics, nutraceuticals, home care and chemical products.

    • Research & Innovation: Oroxcell provides a wide range of services including R&D project management and technical support, international consortium setup and management and regulatory & toxicology consulting.
    We assist you in selecting or developing the best alternative testing methods for your safety and efficacy issues.

    Oroxcell has been certified GLP compliant (Grade A, the highest grade) since 2011 by the French National Medicines and Cosmetics Safety Agency, ANSM.


    Website: http://www.oroxcell.com
    Contact: contact@oroxcell.com



    3D models, ADME, Genotoxicity, Skin sensitization, Toxicology , Pre-clinical, Pharmaceuticals, Dermo-cosmetics, Nutraceuticals, Personal care , Biotechnology, Medical Devices, In-vitro testing, Bioanalysis, Mass spectrometry, Pharmacology, Efficacy, Cytometry, qPCR, Cell culture, and Research

  • Original language

    Highlight Innovation

    Oroxcell is an independent research organization (CRO) offering research services assessing the safety, toxicity and efficacy of active ingredients and finished formulations.

    Specialized in in-vitro testing, particularly in 3D Human Models, Oroxcell is developing its business on two fronts:

    • Safety & efficacy testing: From screening to GLP Compliant studies, we provide well established In-vitro platform, 2D and 3D models, for performing routine and regulatory safety testing, ADME (Absorption, Distribution, Metabolism, and Elimination) and Toxicity (sensitization, phototoxicity and genotoxicity) tests, bioanalytical studies, for evaluating pharmaceuticals, medical devices, cosmetics, nutraceuticals, home care and chemical products.

    • Research & Innovation: Oroxcell provides a wide range of services including R&D project management and technical support, international consortium setup and management and regulatory & toxicology consulting.
    We assist you in selecting or developing the best alternative testing methods for your safety and efficacy issues.

    Oroxcell has been certified GLP compliant (Grade A, the highest grade) since 2011 by the French National Medicines and Cosmetics Safety Agency, ANSM.


    Website: http://www.oroxcell.com
    Contact: contact@oroxcell.com

  • Oroxcell

    At Oroxcell, we are actively committed to bringing top level partnership and services to biotech / pharmaceutical, cosmetic, food, veterinary and home products / Contract Research Organisation/ Société de Recherche Contractuelle / Food health / Alternative methods to animal use/ veterinary / vétérinaire / bioavailability / REACH/ ECHA / in vitro / in vitro toxicity / toxicité / Cellular Absorption / Liver / Hepatic / Hepatic Metabolism / Drug-Drug Interactions / DDI / hepatic DDIs / hepatic DILIs / liver DDIs / DiLis/ CYP 450 and UGT phenotyping / CYP450 induction / Uptake and Efflux transporter inhibition / Bile Salt Export Pump (BSEP) inhibition / Inhibition de la pompe d’exportation de sel biliaires / Drug Drug interactions / Liver / Foi / Intestinal / intestins / renal / reins / FDA Compliance / PK parameters pharmaco-kinetic/ QA / Quality insurance/ Assurance qualité / nutrition health /Nutrition Santé / Skin irritation / irritation cutanée / Irritation oculaire / Occular irritation / CRO / Caco 2 TC7 cells / ready to use plated caco-2 TC7 cells/ 24 or 96 well plates for Caco-2 TC7 cells / BCS Biowaiwer / Generics / Correlation curve / Courbe de corrélation / toxicology /safety assessment / efficacy / ADME / benefit risk / alternative methods to animal use/ safety evaluation / regulatory / GLP compliance study / studies / in-chemico / bio analyses / GLP / good laboratory practices / preclinical studies / ingredients / complex mixtures / microbiota extract / finished products / AOP/ IATA / botanical extracts / formulations / raw materials / extracts / cosmetic / dermo-cosmetic / dermatology / nutrition / pharmaceutic / chemical / medical device / biotechnology / RHE / RHE micronucleus OECD 487 /RHE phototoxicity / RHE IL-18 / biotech / Intestinal / small intestine / Intestinal restitution/ Intestinal toxicity / cutaneous / intestinal absorption : intestinal permeability / Apparent permeability / cutaneous absorption OECD TG 428/ systemic / skin / reconstructed tissues / reconstructed epidermises / ocular / metabolism / absorption / permeation / tissue absorption / Tissue Distribution /tissue homogenates / organ / organes / homogenates / h-CLAT OECD 442 E / OCDE 442E / in vitro ADME / DPRA LC MSMS OECD 442 C / Irritation / genotoxicity / microkentine nucleus / micronuclei / , sensitization, sensitisation / 3T3 NRU / OECD/ 3T3 OECD 432/ / OECD 439 skin irritation / OECD 431 skin corrosion / OECD 492 Eye Irritation / OECD 487 micronucleus / DPRA MSMS OECD 442 C / Direct Peptide Reactivity Assay / phototoxicity / method development / method validation / photosensitisation, photosensitization / mass spectrometry / cell culture / permeation intestinal / 3D organotypic human models / complex mixtures / bioanalysis / botanical extracts / hydrophobic materials / microbiota extracts / cytotoxicity / oils / tar / waxes / finished products / chronic exposure / sensitivity / specificity / accuracy / cornea / gingival / buccal / skin metabolism / métabolisme cutané / screening methods / oral absorption / absorption orale / oral distribution / sub-lingual absorption / extrahepatic Metabolism / protein binding / liaison protéique / keratinosens OECD 442D / tissue-Healing / photo-protection / anti inflammation / calming / anti-sensitisation effect / anti-adipogenesis and slimming / pigmentation and whitening / anti-ageing / antipollution / anti-oxidant / permeation enhancement / barrier function and hydratation / matrix composition and synthesis / usb-lingual permeability / cell lines : HO-1-u-1 / 3D human Oral Epithelium models / subcutaneous toxicity / Ames OECD 471 / multiple reconstructed tissues / h-ClaT / hepatic stability / Stabilité hépatique / intestinal stability gastro intestinal aspirates / jejunum aspirates / duodenum aspirates / ileum aspirates / gastric aspirates / gut aspirates / fed - fasted / food effect / microbiota metabolism / anaerobic / fassif / fessif / absorption distribution metabolism excretion / victims perpetrators / Epiintestinal / Skinethic / Mattek / Episkin / Cellsystem / Straticell / RHE IL-18 / Reconstructed human epidermis / Peau humaine reconstruite / Full thickness / vaginal / buccal / oral / performance of oral formulations / gingival / colonic / colon / medium chain fatty acids / derivatisation / pharmacology / absorbed fraction / resorption / keratine / keratinocytes / whole blood /plasma stability / / micro flora / CYP induction / CYP metabolism / UGT / SULT / phenotyping / dose dependant / linearity / plasma binding / RED / equilibrium dialysis / mass spectrometry / qPCR / mRNA / pharmaceutique / quantitative analysis / fluorescence / luminescence / UV / Oroxcell / CRO / Romainville / 93230 / Seine Saint Denis / Parc Biocitech / Biocitech Park / île de France / Caco-2 TC7 cells / lignée de cellules Caco-2 TC7 / In vitro studies and bioanalytical Services since 2004/ Depuis 2004 / From screening to GLP compliant studies / Expert in ADME-toxicology /Toxicologie / Efficacy / Efficacité / Bioanalysis / bioanalyse and 3D-Organotypic Human Model based assay / Modèles 3D humains / Christophe DINI / CEO / Président / Eric ANDRES / Directeur Scientifique Adjoint / Deputy Scientific Director / Rola BARCHAM / Quality Insurance / Responsable de l'assurance qualité / Shakir SHAKIR / Directeur d'études en bioanalyse / Axelle HUYARD / Technicienne en Bioanalyse / Julien GAUTHEROT / Directeur d'étude en études in vitro / Mouctar BARRY / Technicien en études in vitro / Mélissande DINI / Licence for Caco-2 TC7 cells granted from INSERM / LC-MS/MS / RT-qPCR / UV / Fluorescence / Luminescence / ELISA / Analytical support to in vitro / PK and TK studies / Mixtures complexes testées / Complex Mixture testing / Botanical and micorbiota extracts / extraits botaniques / NASH in vitro assay / biomarkers monitoring : Medium Chain Fatty Acids / surveillance des biomarqueurs : Acides gras à chaîne moyenne / GSH depletion / Bile acids accumulation / GLP Grade A / BPL Grade A / AFSSI / ADEBIOTECH / contact@oroxcell.com / Bioanalyse méthodes de développement jusqu'à la validation / bioanalytical support : method Development up to validation / Allergy / allergies / Caco-2 cell line is used in in vitro models to study intestinal absorption and also for preclinical research such as: Intestinal Pharmacology Intestinal Absorption, including BCS Biowaiver studies: The BCS is well established as a valid approach for waiving the requirements for in vivo BA and BE studies of Class I and Class III drugs and is used to support dossiers of novel oral drug products and generic drug development. Toxicology of the Intestine / MN3D Assay

  • https://www.oroxcell.com/
Corporate interactions BETA
Corporate TypeTweets Articles
No interactions
Similar entities
Loading...
Loading...
Social network dynamics